The University of Tennessee Graduate School of Medicine, Knoxville



The Department of Medicine

William B. Smith, MD

Professor
Division of Cardiology

Education

Medical School
Universidad Autonoma de Guadalajara

Residency
Internal Medicine, University of Tennessee Medical Center

Fellowship
Cardiology, Tulane University Medical Center and Affiliated Hospitals, New Orleans, LA
Nephrology, Vanderbilt University, Nashville, TN

Certifications

American Board of Internal Medicine
American Board of Internal Medicine - Cardiovascular Disease
American Board of Internal Medicine - Nephrology

Current Publications

Smith WB, Hall J, Berg JK, Kazimir M, Yamamoto A, Walker S, Lee CA, Shen Z, Wilson DM, Zhou D, Gillen M, Marbury TC.
Effect of renal impairment on the pharmacokinetics and pharmacodynamics of verinurad, a selective uric acid reabsorption inhibitor. Clinical Drug Investigation. 2018 Aug;38(8):703-713.

Sulkowski MS, Feld JJ, Lawitz E, Felizarta F, Corregidor AM, Khalid O, Ghalib R, Smith WB, Van Eygen V, Luo D, Vijgen L, Gamil M, Kakuda TN, Ouwerkerk-Mahadevan S, Van Remoortere P, Beumont M.
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection. Journal of Viral Hepatitis. 2018 Jun;25(6):631-639. Epub 2018 Feb 6.

Smith WB, Gibson S, Newman GE, Hendon KS, Askelson M, Zhao J, Hantash J, Flanagan B, Larkin JW, Usvyat LA, Thadhani RI, Maddux FW.
The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: A phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation. BMC Nephrology. 2017 Aug 29;18(1):273.

Steinman GL , Smith WB , Westrick ML , Greenberg HE.
Hot button protocol and operational issues between sponsors and sites in clinical pharmacology studies: A moderated forum session. Therapeutic Innovation and Regulatory Science. 2017 May;51(3):298-302.

Smith W, Wan H, Much D, Robinson AG, Martin P.
Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: A phase 4, double-blind, placebo-controlled, randomized, tilt-table study. Clinical Autonomic Research. 2016 Aug;26(4):269-77. Epub 2016 Jul 2.

Rodriguez-Torres M, Glass S, Hill J, Freilich B, Hassman D, Di Bisceglie AM, Taylor JG, Kirby BJ, Dvory-Sobol H, Yang JC, An D, Stamm LM, Brainard DM, Kim S, Krefetz D, Smith W, Marbury T, Lawitz E.
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study. Journal of Viral Hepatitis. 2016 Aug;23(8):614-22. Epub 2016 Mar 9.

Frenck RW Jr, Fiquet A, Gurtman A, van Cleeff M, Davis M, Rubino J, Smith W, Sundaraiyer V, Sidhu M, Emini EA, Gruber WC, Scott DA, Schmoele-Thoma B.
Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine. 2016 Jun 24;34(30):3454-62. Epub 2016 May 5.

Top



Support The University of Tennessee Graduate School of Medicine

The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290

Copyright © 2018